About this FactMed analysis covering adverse side effect reports of minidril patients who developed difficulty in walking.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking minidril reported difficulty in walking to the FDA. A total of 20 minidril drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between minidril and difficulty in walking. In doing so, we compare minidril with other drugs that cause difficulty in walking, to help you evaluate whether or not minidril causes difficulty in walking. Likewise, this page shows the most highly-reported side effects of minidril, so you can see if difficulty in walking ranks among minidril's most well-known side effects.
Summary Statistics
Reports of minidril causing difficulty in walking: 2
Reports of any side effect of minidril : 20
Percentage of minidril patients where difficulty in walking is a reported side effect: 10.0000%

FDA reports of any drug causing difficulty in walking : 5400
Average percentage for all medicated patients where difficulty in walking is reported as a complication: 0.0338%

Physician opinion on minidril as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing minidril:
CONTRACEPTION ( 3 patients )
( 0 patients )
Drugs with high FDA adverse event association with difficulty in walking:

AVONEX (700 patients)
VIOXX (655 patients)
LIPITOR (469 patients)
ASPIRIN (468 patients)
FORTEO (374 patients)
NEURONTIN (299 patients)
CELEBREX (282 patients)
ZOCOR (221 patients)
ATENOLOL (197 patients)
SYNTHROID (194 patients)
PREDNISONE (190 patients)
CRESTOR (165 patients)
NAMENDA (164 patients)
REMICADE (156 patients)
LASIX (147 patients)
HYDROCHLOROTHIAZIDE (145 patients)
BEXTRA (139 patients)
NORVASC (139 patients)
PLAVIX (129 patients)
NEXIUM (124 patients)
ZOLOFT (124 patients)
FUROSEMIDE (122 patients)
FOLIC ACID (120 patients)
LEVOTHYROXINE SODIUM (120 patients)
XANAX (119 patients)
FOSAMAX (116 patients)
VICODIN (114 patients)
PAXIL (111 patients)
COUMADIN (107 patients)
TOPROL-XL (104 patients)
LEVAQUIN (97 patients)
METHOTREXATE (95 patients)
ALL OTHER THERAPEUTIC PRODUCTS (ALL OTHER THERAPEUTIC PRODUCTS) (93 patients)
OXYCONTIN (93 patients)
LISINOPRIL (92 patients)
AMBIEN (82 patients)
PREMARIN (79 patients)
IBUPROFEN (79 patients)
PRILOSEC (78 patients)
OMEPRAZOLE (78 patients)
PREVACID (78 patients)
ALBUTEROL (77 patients)
HUMALOG (77 patients)
DIOVAN (76 patients)
CALCIUM GLUCONATE (76 patients)
ALPRAZOLAM (76 patients)
[THERAPY UNSPECIFIED] (75 patients)
PROZAC (75 patients)
ACETAMINOPHEN (72 patients)
LORAZEPAM (72 patients)
ZETIA (72 patients)
PERCOCET (72 patients)
LEXAPRO (70 patients)
GLUCOPHAGE (69 patients)
REBIF (68 patients)
VALIUM (68 patients)
COZAAR (67 patients)
LYRICA (67 patients)
EVISTA (66 patients)
SEROQUEL (66 patients)
BACLOFEN (65 patients)
VITAMIN E (65 patients)
LANTUS (65 patients)
CYMBALTA (64 patients)
PROTONIX (64 patients)
METFORMIN HCL (64 patients)
INSULIN (64 patients)
DIGOXIN (62 patients)
DEPAKOTE (62 patients)
KLONOPIN (62 patients)
HUMIRA (62 patients)
ZYRTEC (62 patients)
CLONAZEPAM (61 patients)
ACETYLSALICYLIC ACID SRT (59 patients)
ACTOS (59 patients)
VALTREX (59 patients)
GLEEVEC (59 patients)
LEVOXYL (57 patients)
ATIVAN (57 patients)
MULTI-VITAMINS (56 patients)
AMLODIPINE BESYLATE (56 patients)
ZYPREXA (56 patients)
PREDNISOLONE (55 patients)
HUMULIN N (55 patients)
RISPERDAL (55 patients)
TYLENOL (54 patients)
TRAZODONE HCL (54 patients)
ALTACE (53 patients)
NATALIZUMAB (53 patients)
WARFARIN SODIUM (53 patients)
TEGRETOL (53 patients)
SINGULAIR (52 patients)
WELLBUTRIN (51 patients)
POTASSIUM CHLORIDE (51 patients)
ZANTAC (50 patients)
MULTIVITAMIN (49 patients)
SIMVASTATIN (49 patients)
CELEXA (48 patients)
GABAPENTIN (47 patients)
AVANDIA (47 patients)
CARBAMAZEPINE (47 patients)
ALLEGRA (47 patients)
CALCIUM (46 patients)
ALEVE (46 patients)
FLEXERIL (46 patients)
MULTI-VITAMIN (46 patients)
ALLOPURINOL (46 patients)
TOPAMAX (44 patients)
M.V.I. (44 patients)
BENADRYL (44 patients)
METFORMIN (43 patients)
VITAMIN D (43 patients)
ASCORBIC ACID (43 patients)
EFFEXOR XR (43 patients)
LITHIUM CARBONATE (42 patients)
NITROGLYCERIN (42 patients)
SPIRONOLACTONE (42 patients)
ARICEPT (42 patients)
GLIPIZIDE (42 patients)
BOTOX (41 patients)
KEPPRA (41 patients)
ACTONEL (41 patients)
METOPROLOL TARTRATE (41 patients)
BETASERON (41 patients)
THALOMID (40 patients)
PRAVACHOL (40 patients)
TRILEPTAL (40 patients)
DARVOCET-N 100 (40 patients)
GLYBURIDE (40 patients)
ZESTRIL (40 patients)
BACTRIM (40 patients)
DIAZEPAM (40 patients)
ULTRAM (40 patients)
ATORVASTATIN CALCIUM (39 patients)
DEPAKENE (38 patients)
VALPROATE SODIUM (38 patients)
ACCUPRIL (38 patients)
ZOMETA (38 patients)
CLONIDINE (38 patients)
DILANTIN (38 patients)
EFFEXOR (37 patients)
ADVAIR DISKUS 100/50 (37 patients)
DYAZIDE (36 patients)
HYZAAR (36 patients)
RANITIDINE (36 patients)
VOLTAREN (36 patients)
ENALAPRIL MALEATE (35 patients)
DURAGESIC-100 (35 patients)
OXYCODONE HCL (35 patients)
PREDNISONE TAB (35 patients)
COREG (34 patients)
ELAVIL (34 patients)
LAMICTAL (33 patients)
CALCIUM (CALCIUM) (33 patients)
LANSOPRAZOLE (33 patients)
VERAPAMIL (33 patients)
HUMULIN R (32 patients)
AMARYL (32 patients)
VIAGRA (32 patients)
CIPRO (32 patients)
ZANAFLEX (31 patients)
SOMA (31 patients)
AVELOX (31 patients)
LOPRESSOR (31 patients)
SINEMET (31 patients)
NAPROXEN (30 patients)
MOTRIN (30 patients)
IMITREX (30 patients)
REMERON (30 patients)
MEMANTINE HCL (29 patients)
TRICOR (29 patients)
PRIMIDONE (29 patients)
MORPHINE (29 patients)
AVAPRO (29 patients)
COMBIVENT (29 patients)
HUMULIN 70/30 (29 patients)
ZOLPIDEM TARTRATE (29 patients)
DEXAMETHASONE (29 patients)
LANOXIN (28 patients)
PAROXETINE HCL (28 patients)
METOPROLOL (27 patients)
PROVIGIL (27 patients)
POTASSIUM (POTASSIUM) (27 patients)
ZITHROMAX (27 patients)
PEGASYS (27 patients)
IMDUR (27 patients)
AMITRIPTYLINE HCL (27 patients)
VITAMINS (VITAMINS) (27 patients)
ENBREL (26 patients)
ACCUTANE (26 patients)
MIACALCIN (26 patients)
CARDIZEM (26 patients)
REBETOL (26 patients)
TYLENOL (CAPLET) (26 patients)
CLARITIN (26 patients)
REGLAN (26 patients)
DECADRON (26 patients)
FAMOTIDINE (26 patients)
FLONASE (26 patients)
VASOTEC (26 patients)
LOTREL (25 patients)
PENTASA (25 patients)
ACIPHEX (25 patients)
CLOPIDOGREL BISULFATE (25 patients)
INDERAL (25 patients)
MORPHINE SULFATE (25 patients)
CIPROFLOXACIN (25 patients)
FLOMAX (25 patients)
PROPRANOLOL (25 patients)
PRINIVIL (25 patients)
Most common side effects for patients taking minidril:
PREGNANCY (4 patients)
ARTHRALGIA (4 patients)
ANXIETY (3 patients)
SYNOVITIS (3 patients)
OSTEONECROSIS (3 patients)
PAIN (3 patients)
ASTHENIA (3 patients)
DIFFICULTY IN WALKING (2 patients)
ARTHRITIS (2 patients)
DRUG EXPOSURE DURING PREGNANCY (2 patients)
DRUG INEFFECTIVE (2 patients)
MENTAL DISORDER (2 patients)
HAEMATOMA (2 patients)
NO ADVERSE EFFECT (2 patients)
CONVULSION (2 patients)
NIGHTMARE (2 patients)
AGITATION (2 patients)
AGGRESSION (2 patients)
AGRANULOCYTOSIS (2 patients)
BONE MARROW FAILURE (2 patients)
CONDITION AGGRAVATED (2 patients)
TRISMUS (2 patients)
ABNORMAL DREAMS (2 patients)
NORMAL NEWBORN (1 patients)
PHOSPHENES (1 patients)
PHOTOPHOBIA (1 patients)
POST PROCEDURAL COMPLICATION (1 patients)
ORAL INTAKE REDUCED (1 patients)
VOMITING (1 patients)
RASH (1 patients)
SLEEP DISORDER (1 patients)
SPONTANEOUS HAEMATOMA (1 patients)
VERTIGO (1 patients)
STATUS EPILEPTICUS (1 patients)
STEVENS-JOHNSON SYNDROME (1 patients)
TRICHIASIS (1 patients)
THROMBOSIS (1 patients)
DRY EYE (1 patients)
DYSURIA (1 patients)
DRUG INTERACTION (1 patients)
DEPRESSION (1 patients)
CYTOLYTIC HEPATITIS (1 patients)
CONJUNCTIVITIS (1 patients)
CONJUNCTIVAL SCAR (1 patients)
CONGENITAL ANOMALY (1 patients)
BONE INFARCTION (1 patients)
ENCEPHALOCELE (1 patients)
FALL (1 patients)
HYPERTENSION (1 patients)
MENINGOCELE (1 patients)
LOSS OF CONSCIOUSNESS (1 patients)
LABORATORY TEST ABNORMAL (1 patients)
KERATITIS (1 patients)
INSOMNIA (1 patients)
INFLAMMATION (1 patients)
INFECTION (1 patients)
HYPERTENSIVE ENCEPHALOPATHY (1 patients)
ABASIA (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for minidril


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about difficulty in walking and minidril, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking minidril, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in minidril. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for minidril experts. If you are a healthcare provider experienced in prescribing minidril, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use